Recent News

• 04.01.2025 - HCW Biologics Announces 1-for-40 Reverse Stock Split
• 04.01.2025 - HCW Biologics Announces 1-for-40 Reverse Stock Split
• 03.28.2025 - HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results
• 03.28.2025 - HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results
• 03.06.2025 - HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements
• 03.06.2025 - HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

Recent Filings

• 04.01.2025 - EX-99.1 EX-99.1
• 04.01.2025 - 8-K Current report
• 04.01.2025 - 8-K Current report
• 03.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.28.2025 - EX-99.1 EX-99.1
• 03.28.2025 - 8-K Current report
• 03.19.2025 - 8-K Current report
• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 8-K Current report
• 02.26.2025 - CT ORDER Confidential treatment order